FindMyKOL

Yolanda Mageto, MD

Enriched profile

Medical Director of Interstitial Lung Disease · Baylor University Medical Center at Dallas

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Dallas, TX · South Central · United StatesSpecialtyPulmonary DiseaseFocusInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis+4
Active KOLFindMyKOL type: EliteLatest publication2025Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Yolanda Mageto is Medical Director of Interstitial Lung Disease at Baylor University Medical Center at Dallas. OpenAlex indexes 35 publications with 4,267 citations (h-index 19); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 23 Oct 2026

Overview

Updated 25 Oct 2026

Yolanda Mageto, MD, is Medical Director of Interstitial Lung Disease at Baylor University Medical Center at Dallas (Baylor Scott & White Health). The public record shows 35 publications with 4,267 citations (h-index 19), centered on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease (COPD) Research, Occupational and environmental lung diseases. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 19 companies.

  • Most recent indexed publication: 2025 · American journal of respiratory and critical care medicine
  • Top research focus: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 19 companies

Generated from the cited public record · current as of 25 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Idiopathic Pulmonary Fibrosis3 trialsLung Diseases, Interstitial1 trialAsthma1 trialAspergillosis1 trialAspergillosis, Allergic Bronchopulmonary1 trialPulmonary Aspergillosis1 trialPulmonary HypertensionCOPD

Research focus

OpenAlex concept fingerprint
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) ResearchOccupational and environmental lung diseasesSystemic Sclerosis and Related DiseasesPulmonary Hypertension Research and Treatments

Drugs & molecules

across trials, industry payments and publications
Ofevgeneric · NintedanibClinical trials—Industry payments22Publications1Esbrietgeneric · PirfenidoneClinical trials—Industry payments5Publications2Acthargeneric · CorticotropinClinical trials—Industry payments41Publications—Tyvasogeneric · TreprostinilClinical trials—Industry payments20Publications—Arikaycegeneric · AmikacinClinical trials—Industry payments9Publications—Fasenrageneric · BenralizumabClinical trials—Industry payments7Publications—Nucalageneric · MepolizumabClinical trials—Industry payments6Publications—Dupixentgeneric · DupilumabClinical trials—Industry payments5Publications—Brinsuprigeneric · BrensocatibClinical trials—Industry payments4Publications—Prolastin-C LiquidClinical trials—Industry payments4Publications—Zemairageneric · Alpha 1-antitrypsinClinical trials—Industry payments3Publications—Tezspiregeneric · TezepelumabClinical trials—Industry payments2Publications—

Works with

trial sponsors and companies reporting payments
Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments100ANI Pharmaceuticals, Inc.Clinical trials—Industry payments39United Therapeutics CorporationClinical trials—Industry payments23AstraZeneca Pharmaceuticals LPClinical trials—Industry payments9Insmed, Inc.Clinical trials—Industry payments9CSL BehringClinical trials—Industry payments8Genentech USA, Inc.Clinical trials—Industry payments7GlaxoSmithKline, LLC.Clinical trials—Industry payments6Genzyme CorporationClinical trials—Industry payments4Grifols USA, LLCClinical trials—Industry payments4Vifor Pharma, Inc.Clinical trials—Industry payments3E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments2Itamar Medical IncClinical trials—Industry payments2Mallinckrodt Hospital Products Inc.Clinical trials—Industry payments2Philips North America LLCClinical trials—Industry payments2AbbVie Inc.Clinical trials—Industry payments1Baylor Research InstituteClinical trials1Industry payments—Duke UniversityClinical trials1Industry payments—Kyntra BioClinical trials1Industry payments—Merck Sharp & Dohme LLCClinical trials—Industry payments1Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments1Rein TherapeuticsClinical trials1Industry payments—Verona Pharma, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
35publications

Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.

4,267citations

Total citations across indexed works.

19h-index

Hirsch index (OpenAlex). i10-index 21.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
19companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 25 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

All 4 trial records: search, sort and filter.Explore →

Industry payments

Updated 25 Oct 2026

19 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 37 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 25 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Most-cited works

by citation count (OpenAlex)
  1. 01
    Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
    Article1,054 citations2020
    doi.org ↗
  2. 02
    Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
    Article571 citations2020
    doi.org ↗
  3. 03
    Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening
    Article468 citations2015
    doi.org ↗
  4. 04
    Treatment of Idiopathic Pulmonary Fibrosis with a New Antifibrotic Agent, Pirfenidone: Results of a Prospective, Open-label Phase II Study
    Article468 citations1999
    doi.org ↗
  5. 05
    The Accuracy of the Clinical Diagnosis of New-Onset Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Disease
    Article401 citations1999
    doi.org ↗
All 35 cited works: search, sort and filter.Explore →

Network

Updated 25 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Ganesh Raghu11LISA H. LANCASTER11Amy Hajari Case8Zeenat Safdar8Murali Ramaswamy8Justin M. Oldham7Kevin R. Flaherty7Tracy Luckhardt7Mary E. Strek7Daniel F. Dilling7Mridu Gulati7Rajat Walia6Tristan J. Huie6Sonye Karen Danoff6Joseph A. Lasky6Timothy P. M. Whelan6Paul Sachs5John A. Belperio5Mary Beth Scholand5Megan Lee Neely5R. Raj5João A. de Andrade5Shirin Shafazand5Lake Daniel Morrison5Andrew M. Namen5Robert J. Kaner5Nishant Gupta5Randolph J. Lipchik5Rany Condos5FRANCIS C. CORDOVA5Laurie D. Snyder5Timothy N. Liesching5Jason Lobo5Marilyn K. Glassberg5John Fitzgerald5Kalpalatha K. Guntupalli5Scott H. Beegle5David L. Hotchkin5Jeremy Tabak5Marta Kokoszynska4

Online presence

Updated 25 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/yolanda-mageto-md

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    bswhealth.com/physician/yolanda-mageto

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bswhealth.com ↗
  • Other

    cmeoutfitters.com/activity/leveling-the-playing-field-overcoming-barriers-to-equitable-care-in-ild

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cmeoutfitters.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 25 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Fellowship

    Pulmonary Critical Care, University of Washington Medical Center

    1999
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bswhealth.com ↗
  • Residency

    Internal Medicine, UT Southwestern Medical Center

    1994
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bswhealth.com ↗
  • MD

    Washington University School of Medicine

    1991
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bswhealth.com ↗
  • MPH (credential as listed with name)
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bswhealth.com ↗
  • Board certified

    Internal Medicine, American Board of Internal Medicine

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bswhealth.com ↗
  • Board certified

    Pulmonary Disease, American Board of Internal Medicine

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bswhealth.com ↗

Editorial & leadership roles

journal and society appointments
  • Board of Directors

    American Thoracic Society

    2023
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thoracic.org ↗
  • Chair

    Planning and Evaluation Committee, American Thoracic Society

    2023
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thoracic.org ↗
  • Chair

    Membership Committee, American Thoracic Society

    2017
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thoracic.org ↗
  • Finance Committee

    American Thoracic Society (current)

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thoracic.org ↗
  • Awards Committee

    American Thoracic Society (current)

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thoracic.org ↗

Secondary affiliations

appointments beyond the home institution
  • Professor of Medicine

    Texas A&M School of Medicine, Division of Pulmonary and Critical Care Medicine

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thoracic.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.